Panel discussion on the treatment of adolescent and young adult lymphoma patients
Catherine Bollard et al.
The importance of diagnosing DLBCL on a molecular level and how it will improve treatment
Upcoming trials for DLBCL: R-CHOP with acalabrutinib and obinutuzumab with checkpoint inhibitor
The unmet need in DLBCL
The next steps for TGR-1202 and targeting the gene c-Myc